GaldermaOpensupNewChapterforSculptrawithMDRCertificationandNewExpandedIndicationforBody
===2025/12/5 15:03:37===
nism of Action Unique to PLLA. Poster presented at ASDS 2024 Annual Meeting; October 17-20, 2024; Orlando, Florida, United States.
Waibel J, et al. Gene Analysis of Biostimulators: PLLA-SCA Triggers Regenerative Morphogenesis while CaHA-R Induces Inflammation upon Facial Injection. Poster presented at ASDS 2024; October 17-20, 2024; Orlando, Florida, United States.
Huth S, et al. Molecular Insights into the effects of PLLA_SCA on Gene Expression.J Drugs Dermatol.2024;23(4):285–288.
Galderma. Data on File (MA-46589).
Vleggaar D, et al. Consensus recommendations on the use of injectable poly-L-lactic-acid for facial and nonfacial volumization.J Drugs Dermatol.2014;13(4 Suppl):s44–s51.
Widgegrow J, et al. A randomized, comparative study describing the gene signatures of poly-l-lactic acid (PLLA-SCA) and calcium hydroxylapaptite (CaHA) in the treatment of nasolabial folds). Poster presented at IMCAS World Congress; Feb
=*=*=*=*=*=
当前为第11/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页